EBS : Summary for Emergent Biosolutions, Inc. - Yahoo Finance

U.S. Markets closed

Emergent BioSolutions Inc. (EBS)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
28.82+0.46 (+1.62%)
At close: 4:02PM EDT
People also watch
ACORMNTAALNYOSIRCBM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close28.36
Open28.47
Bid0.00 x
Ask0.00 x
Day's Range28.06 - 29.06
52 Week Range24.47 - 44.38
Volume386,383
Avg. Volume369,267
Market Cap1.17B
Beta1.46
PE Ratio (TTM)25.48
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Emergent BioSolutions, Inc. breached its 50 day moving average in a Bearish Manner : EBS-US : March 20, 2017
    Capital Cube6 days ago

    Emergent BioSolutions, Inc. breached its 50 day moving average in a Bearish Manner : EBS-US : March 20, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Emergent BioSolutions, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • American City Business Journals6 days ago

    Emergent BioSolutions gets $100 million anthrax contract from feds

    Gaithersburg-based Emergent BioSolutions Inc. won another lucrative anthrax contract from the feds, this time totaling $100 million over two years. Emergent (EBS) received the contract through the Biomedical Advanced Research and Development Authority to add more of its anthrax vaccine, BioThrax, to the country's national stockpile. The company first announced the planned purchase in December, along with another Centers for Disease Control and Prevention contract worth up to $911 million for 29.4 million doses of BioThrax through 2021.

  • GlobeNewswire9 days ago

    Emergent BioSolutions Awarded $100 Million BARDA Contract for BioThrax Deliveries to the Strategic National Stockpile

    GAITHERSBURG, Md., March 17, 2017-- Emergent BioSolutions Inc. today announced that it has signed a two-year contract with the Biomedical Advanced Research and Development Authority, a division within ...